Monday, May 4, 2020

Former FDA chief Dr. Scott Gottlieb on slowing spread, antibody testing and more - YouTube

Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina, and former FDA commissioner, joins "Squawk Box" to discuss the latest on Covid-19, remdesivir and how we can learn to live with our new normal. The Food and Drug Administration said it is tightening rules for antibody tests after it became aware of “a concerning number” of tests performing poorly or being marketed inappropriately. Manufacturers will need to submit emergency use authorization forms and data proving the tests work within 10 days or face possible removal. So far, 12 antibody tests have been authorized by the FDA for emergency use, and more than 250 tests are currently the subject of a pre-EUA or EUA review, FDA Commissioner Stephen Hahn told reporters Monday. Antibody tests can indicate whether a person has had Covid-19 in the past and was either asymptomatic or recovered. U.S. officials and businesses have been pouring money into antibody testing, hoping it will give people the confidence to return to work and reopen parts of the economy. —Berkeley Lovelace Jr., Will Feuer


| Permalink